NCT06132477View on ClinicalTrials.gov

Impact GLP-1 Agonists Following Bariatric

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2030

Conditions
Morbid ObesityMetabolic SyndromeDiabetes MellitusHypertensionObstructive Sleep Apnea of Adult
Interventions
DRUG

GLP-1 receptor agonist

Randomized to continue or discontinue GLP-1 receptor agonists after bariatric surgery

Trial Locations (1)

65201

RECRUITING

University of Missouri Hospital, Columbia

All Listed Sponsors
collaborator

American Society for Metabolic and Bariatric Surgery

OTHER

lead

University of Missouri-Columbia

OTHER